Virus Risk Mitigation in Viral Vector and Gene Therapy Cell Culture Media

Thank you - Your Download is Available Below

Virus Risk Mitigation in Viral Vector and Gene Therapy Cell Culture Media

PDF | 538.3 KB

Virus Risk Mitigation in Viral Vector and Gene Therapy Cell Culture Media

This poster underscores the importance of virus risk mitigation in the production of viral vectors and gene therapies, detailing a three-tiered strategy that evolves with therapeutic advancements. It discusses the role of chemically defined media, virus clearance, and closed aseptic processing in ensuring safety at a commercial scale, and highlights the effectiveness of Virosart^® Media in virus filtration, with an emphasis on the necessity of advanced screening technologies for cell culture media and raw materials.

Key Takeaways

Learn how a three-tiered viral risk mitigation strategy supports production safety for viral vector and gene therapy.
See why using chemically defined media, virus clearance steps, and closed aseptic processing is crucial for commercialization.
Understand what makes advanced screening technologies important for virus risk mitigation in cell culture media and raw materials.

Clear form data

Please Complete the Form

First Name *

Last Name *

E-Mail *

Phone Number *

Company *

Job Title *

Address *

Country *

Postal Code *

I would like to sign up for newsletters from Sartorius (Sartorius AG and its affiliated companies) based of my personal interests.
I can revoke my consent at any time with effect for the future by sending an e-mail to unsubscribe@sartorius.com or by clicking on the "unsubscribe" link in e-mails I have received.

* These fields are required Information on the use of your data can be found in our privacy policy

Thank you - Your Download is Available Below

Virus Risk Mitigation in Viral Vector and Gene Therapy Cell Culture Media

Virus Risk Mitigation in Viral Vector and Gene Therapy Cell Culture Media

Key Takeaways

Please Complete the Form

Complete Form to Access the File